ARCHIVES

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.

July 1, 2005

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

George Sledge Jr. Named Oncology Chief at Stanford University

October 12, 2012

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

November 21, 1980

FY 1984 Bypass Budget Shown By Mechanism,, Research Program

July 2, 1982